108 related articles for article (PubMed ID: 2652729)
1. Immunohistology of liver allografts in recipients managed with prophylactic OKT3.
Rohrer RJ; Jenkins RL; Khettry U; Pinson CW; Gallik-Karlson C; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):2249-50. PubMed ID: 2652729
[No Abstract] [Full Text] [Related]
2. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
Hamilton G; Mühlbacher F; Steininger R; Havel M; Kreuzer S; Laengle F; Piza F
Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
[No Abstract] [Full Text] [Related]
3. Histologic response to OKT3 therapy for hepatic allograft rejection.
Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
[No Abstract] [Full Text] [Related]
4. Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
McDiarmid SV; Millis M; Terashita G; Ament ME; Busuttil R; Terasaki P
Transplant Proc; 1990 Aug; 22(4):1774-6. PubMed ID: 2117806
[No Abstract] [Full Text] [Related]
5. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
Hricik DE; Zarconi J; Schulak JA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
[No Abstract] [Full Text] [Related]
6. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Blümke M; Kirste G; Wanner U; Wilms H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
[No Abstract] [Full Text] [Related]
7. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
8. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
9. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
[No Abstract] [Full Text] [Related]
10. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
11. Cardiac transplantation in the sixth decade of life.
Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
[No Abstract] [Full Text] [Related]
12. Prophylactic ATG or OKT3 in liver transplantation in the presence of contraindications to cyclosporine (CyA) or azathioprine (AZA).
Gugenheim J; Samuel D; Chaland P; Saliba F; Bismuth H
Transplant Proc; 1989 Feb; 21(1 Pt 2):2257. PubMed ID: 2652733
[No Abstract] [Full Text] [Related]
13. Renal transplantation in children using cyclosporin A and azathioprine.
Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
[No Abstract] [Full Text] [Related]
14. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
[No Abstract] [Full Text] [Related]
15. Preservation of renal function using OKT3 in liver transplant patients.
Millis JM; Baquerizo A; Saleh S; Danovitch GM; Busuttil RW
Transplant Proc; 1989 Jun; 21(3):3551-2. PubMed ID: 2662524
[No Abstract] [Full Text] [Related]
16. Clinical development of Orthoclone OKT3.
Cosimi AB
Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
[No Abstract] [Full Text] [Related]
17. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2431-3. PubMed ID: 3079083
[No Abstract] [Full Text] [Related]
18. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.
De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C
Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800
[No Abstract] [Full Text] [Related]
19. Quadruple immunosuppressive therapy for liver transplantation.
Kalayoglu M; Stratta RJ; Hoffmann RM; Sollinger HW; Belzer FO
Transplant Proc; 1988 Feb; 20(1 Suppl 1):524-9. PubMed ID: 3279646
[No Abstract] [Full Text] [Related]
20. Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
Dendorfer U; Hillebrand G; Kasper C; Smely S; Weschka M; Hammer C; Racenberg J; Gurland HJ; Land W
Transplant Proc; 1990 Aug; 22(4):1789-90. PubMed ID: 2389450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
